J.Jpn. Surg. Soc.
ISSN 1880-1129

[Abstract] [Full Text PDF] （in Japanese / 3123KB） [Members Only And Two Factor Auth.]

J.Jpn. Surg. Soc.. 97(4): 312-316, 1996

Feature topic

ADJUVANT CHEMOTHERAPY FOR ADVANCED GASTRIC CANCER

Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan

Hiroshi Furukawa, Masahiro Hiratsuka, Takeshi Iwanaga, Shingi Imaoka, Osamu Ishikawa, Toshiyuki Kabuto, Yo Sasaki, Masao Kameyama, Hiroaki Ohigashi, Shoji Nakamori, Hiroshi Nakano, Takushi Yasuda

For recent 40 years, many authors reported the results of adjuvant chemotherapy for advanced gastric cancer including sfluorouracil, uracil and tegafur, mitomycin C, cytosine arabinoside, OK-432, adriamycin, methotrexate, and cis-pltatin in solitary use of combinations. It is difficult to find a standard effective adjuvant chemotherapy for advanced gastric cancer in these reports. The resasons of this unclearness were as follows ; (1) In phase In studies, surgery alone was not a control group in some reports. (2) The number of patients was too small to evaluate statistically. (3) Inter-institutional differences had important roles in the results of multicenter study in the other studies. For the future plans on adjuvant chemotherapy, it is important to make a simple designed protocol, and perform it as a multicenter study including institutions with minimum inter-institutional differences.

<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.